PTGS2 and COVID-19: Testes of COVID-19 patients also presented elevated mRNA levels of histamine H4 receptor (HRH4), cyclooxygenase-2 (COX2) and monocyte chemoattractant protein-1 (MCP1; 10x higher) (Fig. 5h).